Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sequential gene expression profiling during treatment for identification of predictive markers and novel therapeutic targets in chronic lymphocytic leukemia.
Shehata M, Demirtas D, Schnabl S, Hilgarth M, Hubmann R, Fonatsch C, Schwarzinger I, Hopfinger G, Eigenberger K, Heintel D, Porpaczy E, Vanura K, Hauswirth A, Schwarzmeier JD, Gaiger A, Stilgenbauer S, Hallek M, Bilban M, Jäger U. Shehata M, et al. Among authors: schwarzinger i. Leukemia. 2010 Dec;24(12):2122-7. doi: 10.1038/leu.2010.220. Epub 2010 Oct 22. Leukemia. 2010. PMID: 20966934 No abstract available.
Myelodysplastic syndrome/acute myeloid leukemia supervening previously untreated chronic B-lymphocytic leukemia: demonstration of the concomitant presence of two different malignant clones by immunologic and molecular analysis.
Mitterbauer G, Schwarzmeier J, Mitterbauer M, Jaeger U, Fritsch G, Schwarzinger I. Mitterbauer G, et al. Among authors: schwarzinger i. Ann Hematol. 1997 Apr;74(4):193-7. doi: 10.1007/s002770050282. Ann Hematol. 1997. PMID: 9174549
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants.
Keil F, Prinz E, Kalhs P, Lechner K, Moser K, Schwarzinger I, Jäger U, Fonatsch C, Worel N, Mannhalter C, Rabitsch W, Loidolt H, Schulenburg A, Mitterbauer M, Höcker P, Greinix HT. Keil F, et al. Among authors: schwarzinger i. Leukemia. 2001 Mar;15(3):355-61. doi: 10.1038/sj.leu.2402048. Leukemia. 2001. PMID: 11237057
Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes.
Wimazal F, Sperr WR, Kundi M, Meidlinger P, Fonatsch C, Jordan JH, Thalhammer-Scherrer R, Schwarzinger I, Geissler K, Lechner K, Valent P. Wimazal F, et al. Among authors: schwarzinger i. Leuk Res. 2001 Apr;25(4):287-94. doi: 10.1016/s0145-2126(00)00140-5. Leuk Res. 2001. PMID: 11248325
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions.
Laczika K, Mitterbauer G, Mitterbauer M, Knöbl P, Schwarzinger I, Greinix HT, Rabitsch W, Fonatsch C, Mannhalter C, Lechner K, Jaeger U. Laczika K, et al. Among authors: schwarzinger i. Leuk Lymphoma. 2001 Sep-Oct;42(5):923-31. doi: 10.3109/10428190109097711. Leuk Lymphoma. 2001. PMID: 11697647 Clinical Trial.
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse.
Weltermann A, Fonatsch C, Haas OA, Greinix HT, Kahls P, Mitterbauer G, Jäger U, Kainz B, Geissler K, Valent P, Sperr WR, Knöbl P, Schwarzinger I, Gleiss A, Lechner K. Weltermann A, et al. Among authors: schwarzinger i. Leukemia. 2004 Feb;18(2):293-302. doi: 10.1038/sj.leu.2403243. Leukemia. 2004. PMID: 14671635
168 results